Abivax S.A.

NASDAQ: ABVX · Real-Time Price · USD
74.43
2.54 (3.53%)
At close: Aug 21, 2025, 3:59 PM
73.85
-0.78%
After-hours: Aug 21, 2025, 07:27 PM EDT

Abivax S.A. Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Revenue
7.4M 3.39M 2.33M 2.25M 2.25M 2.23M n/a n/a
Cost of Revenue
n/a n/a 378K 329K 32K 39K 124K 32K
Gross Profit
7.4M 3.39M 2.33M 2.25M 2.25M 2.23M -124K -32K
Operating Income
-132.99M -40M -92.46M -39.53M -38.8M -18.63M -25.69M -26.53M
Interest Income
n/a n/a n/a n/a 113K 15K 84K n/a
Pretax Income
-135.42M -40.82M -98.05M -54.19M -42.55M -31.77M -27.42M -18.14M
Net Income
-94.6M -40.82M -95.79M -51.95M -40.29M -29.55M -24.83M -16.53M
Selling & General & Admin
16.74M 22.16M 21.53M 6.58M 5.27M 2.22M 2.3M 2.45M
Research & Development
81.88M 32.33M 70.55M 32.62M 32.84M 15.11M 23.25M 23.95M
Other Expenses
41.76M -28K n/a -7K -1K 10.93M -17K -96K
Operating Expenses
140.38M 43.39M 92.08M 39.21M 37.99M 28.26M 25.56M 26.5M
Interest Expense
n/a n/a 5.7M 14.7M 1.81M 2.13M 2.18M 1.03M
Selling & Marketing Expenses
1.73M 2.11M 5.9M n/a n/a n/a n/a n/a
Cost & Expenses
140.38M 43.39M 92.46M 39.53M 38.02M 18.63M 25.69M 26.53M
Income Tax Expense
n/a n/a -2.26M -2.23M -2.26M -2.22M -2.59M -1.61M
Shares Outstanding (Basic)
63.17M 62.92M 48.29M 35.9M 22.3M 16.77M 16.76M 14.66M
Shares Outstanding (Diluted)
63.17M 62.92M 48.29M 35.9M 22.3M 16.77M 16.76M 14.66M
EPS (Basic)
-0.75 -0.65 -1.98 -1.45 -1.81 -1.76 -1.48 -1.13
EPS (Diluted)
-0.75 -0.65 -1.98 -1.45 -1.81 -1.76 -1.48 -1.13
EBITDA
-46.03M -39.91M -92.08M -39.21M -36.15M -15.02M -25.56M -26.5M
EBIT
-92.99M -40M -92.34M -39.49M -36.19M -15.05M -25.24M -26.52M
Depreciation & Amortization
464.5K 85.5K 378K 329K 32K 39K 124K 32K